Genprex around 100% profit next weeks

NASDAQ:GNPX   Genprex, Inc.
About Genprex Inc
Genprex, Inc. operates as a biotechnology company. The Company discovers and develops immunogene therapies for cancer treatment, as well as provides clinical research, gene therapies, consulting, and other related medical services. Genprex serves customers in the United States.

Bloomberg Profile:


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.